WebMay 4, 2024 · The recalled lots include 15 mg, 30 mg, 60 mg, 90 mg and 120 mg pills packed in 100-count and 7-count bottles. See the full list of recalled drugs on the FDA … WebJanuary 21, 2024. Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where the muscles ...
Thyroid medication recalled for potency concerns, FDA says
WebFeb 2, 2024 · Consumers and healthcare providers with questions about the recall can contact IBSA Pharma Inc. at 1-800-587-3513 Monday through Friday between 9 a.m. … WebSep 22, 2024 · The U.S. Food and Drug Administration (FDA) announced the NP Thyroid medication recall Sept. 17, the same day that Acella voluntarily recalled the products. According to the FDA, the recalled lots of NP Thyroid medication do not have enough of the active ingredient levothyroxine (T4). Because the levels of this drug may be as low … sherbrooke hotel montreal
What’s REALLY Going on With the FDA and Natural Desiccated Thyroid Drugs?
WebMay 3, 2024 · Last May, Acella Pharmaceuticals pulled 13 lots of its prescription hypothyroidism med NP Thyroid in the U.S. after testing revealed an excess of one of the drug's main ingredients. Web11 rows · Drug recalls are actions taken by a firm to remove a product from the … WebFeb 1, 2024 · February 01, 2024 -- IBSA Pharma Inc. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. This voluntary recall has been initiated because these lots may be subpotent. The company’s analyses show a slight decrease below 95.0% of its labeled amount in levothyroxine sodium (T4) … sprint pcs store near me